Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
- Status
- TERMINATED
- Phase
- N/A
Personalized Risk Stratification Model of Follicular Lymphoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Status
- RECRUITING
- Phase
- N/A
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Status
- RECRUITING
- Phase
- PHASE2
A Study of PLX2853 in Advanced Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Constitutional Genetics in Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
A Phase I Study of Intravenous CHO-H01 in Patients With Refractory or Relapsed Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Clonal Evolution in Follicular Lymphoma
- Status
- RECRUITING
- Phase
- N/A
TGR1202 in Relapsed and Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
- Status
- TERMINATED
- Phase
- PHASE1